SlideShare une entreprise Scribd logo
1  sur  82
Télécharger pour lire hors ligne
Renal Disease and Dialysis
Objectives
 CKD
 Dialysis
Chronic Kidney Disease
DIALYSIS
HD, PD, CAPD
Common Diagnosis
 CKD (ESRD) secondary to hypertensive
nephropathy
 Acute gastroenteritis
 AKI,Acute gastroenteritis
 CKD (ESRD) secondary to chronic
glomerulonephritis
 CKD(ESRD) secondary to Diabetic
nephropathy
Indications
End-stage renal failure – GFR less than 5
ml/min( dialysis or renal transplant is
needed).
Contd…
 Clinical
 Fluid overload not responding to diuretics.
 Uremic convulsion
 Persistent dyspnea, vomiting and restlessness.
 Signs of pericarditis, pericardial effusion, pericardial
friction rub.
 Biochemical
Chemical ARF CRF
Normal
Urea >35 mmol/L >40 mmol/L 2.5-6.5
Creatinine >12-14 mg/dl >12-14 mg/dl 0.6-1.3
Potassium >6.5 Meq/L >6.5 Meq/L 3.5-5.5
PH <7.1 <7. 1 7.35-
7.45
Hours for hemodialysis
 Hemodialysis usually is done three times a
week.
 Each treatment lasts from 2 to 4 hours. During
treatment, patient can read, write, sleep, talk, or
watchTV.
Dialysis
Hemodialysis
 Semipermeable membrane
 Solute removal via passive diffusion
◦ Inversely proportional to the size (ie effective
removal of K, urea, C; not of PO4)
Dialysis
Ultrafiltration
 use of hydrostatic pressure gradient to
induce convection (filtration of water)
 solvent drag (pulls dissolved solutes)
across
 removal of excess fluid
CVVH
 highly permeable membrane
 fluid and solute removal via ultrafiltration
 filtrate is discarded
 replacement fluid is infused similar to
plasma (but no K, urea, Cr, PO4)
 used in ICU, runs 12-24h, through double
lumen catheter
 less drastic fluid shifts
Preparations for Dialysis
 Articles needed for dialysis
i. Arteriovenous fistula : common venous
access for HD. Usually radial artery and
cephalic vein are anastomosed.
 Dialyser set
 Arteriovenous set
 Fistula needle
 Haemodialysis fluid with bicarbonate powder
(5 litre)
 IV set
…
 Inj. 25% Dextrose : If associated with Diabetes,
Diabetic Uropathy , Diabetic Nephropathy.
 Inj. Normal Saline(500 ml)
 Inj Avil
 Inj Heparin
 Syringes : 20, 10 & 5 cc.
…
ii.Via Femoral (It is done through through femoral
vein
 Dialyser set
 Arteriovenous set
 Femoral Catheter
 GuideWire Straight tip (70cm)
 Haemodialysis fluid with Bicarbonate powder (
5litre)
 IV canula
…
 IV set
 Inj. 25 % Dextrose
 Inj 2% Xylocaine
 Inj. Normal Saline 500ml
 Inj.Avil
 Inj. Heparin
 Syringes : 20, 10 , 5 cc.
Chemicals Used In Dialysis
Sodium Hypochlorite
Hydrogen Peroxide
Formaldehyde
Part A and part B
i. Part A
Concentrate contains :
 Sodium Chloride : 173.65 gm/l
 Potassium Chloride : 5.06 gm/l
 Calcium Chloride : 8.75 gm/l
 Magnesium Chloride : 5.18 gm/l
 Glacial Acetic Acid : 8.17gm/l
…
ii. Part B
 Sodium Bicarbonate : 626gm
 Sodium Chloride : 221 gm
(mixed with 9 litres of Reverse Osmosis water)
Medication used during dialysis
 Heparin :6000 IU
Side Effects of Heparin : Pruritus, Allergy
,Osteoporosis, Hyperlipidemia,
Thrombocytopenia
 Avil : 1 Ampoule (each ml contains 22.75 mg)
 Hydrocortisone :1vial = 100 mg
 25% dextrose:
 Epofit
Heparin free case
 Periodic saline rinse
 Every 15-30 minutes , rinse the dialyser rapidly
with 100-250 ml of saline while occluding the
blood inlet line.
 The purpose of the periodic rinsing is to allow
inspection of a hollow-fiber dialyser for
evidence of clotting.
Hypoglycemia: It can develop in diabetic patient
treated with either hemodialysis or peritoneal
dialysis and is usually due to reduced insulin
catabolism and to reduce intake and absorption
of food.
 In diabetic patients hemodialysis solution should
always contain about 200mg/dl glucose if not
added then severe hypoglycemia during or soon
after hemodialysis can result.
Investigation
 Haemoglobin :15 days
 Urea, creatinine,Na+, K+ : 1 month
 Serology : 2 months
 Range of
conductivity:14.7mMho13.2mMho
 Normal range of TMP: -100 to 500
 The usual flow rate for adult patient is
200-350 ml/min
Dialysis
Financial
 Amount of 5 lakhs is provided by the
government for dialysis
Complications
 Infection
 Fever and chills
 Catheter clotting
 Hypotension
 Muscle cramps
 Septicemia
 Hepatits C
Prognosis(Life expectancy)
 2-4 years in haemodialysis
 9-10 years in CAPD
 Disequilibrium Syndrome : It is the set of
systemic and neurologic symptoms often
associated with characteristic EEG findings that
can occur either during or soon after dialysis .
Early manifestation:nausea ,vomiting
,restlesssness ,headache
Serious manifestation : coma, seizure
Care of vascular access
 Check access before each treatment.
 Keep access clean at all times. Do not use cream or
lotion over the site.
 Use access site only for dialysis.
 Be careful not to bump or cut access.
 Don’t put a blood pressure cuff on access arm.
 Remove jewellary or tight clothes over access site.
 Don’t sleep with access arm under your head or
body.
 Don’t lift heavy objects or put pressure on access
arm.
Diet Pattern
 Fluid restriction: total intake<1 lit/day in oliguric
ARF and total intake <urine output + extra
renal loss
 Total caloric intake– 35~ 50 kcal/kg/day
to avoid catabolism
 Salt restriction– 2~4 g/day
 Potassium intake– 40 meq/day
 Phosphorus intake– 800 mg/day
 Daily protein intake of between 0.60 and
0.75gm/kg/day.
 The normal level of potassium intake is 3.5-5.0
mEq/l.
 2-3g/day of sodium is allowed in CKD patient.
 Phosphorus consumption for normal people as well
as people with CKD for non dialysis is 2.7-4.6mg/dl.
 For CKD dialysis patients the target range is 3.5-
5.5mg/dl.
Dialyzer Re-use
1. Reprocessing technique : The major steps in
dialyzer reuse are rinsing , cleaning,
measurement of dialyzer performance,
disinfection/sterilization and germicide
removal.
a) Rinsing and reverse ultrafiltration
b) Cleaning : Sodium hypochlorite
c) Other cleaning agents : Hydrogen
peroxide,formalin
Nursing consideration
Pre Haemodialysis:
 Correct identification of patient, using hospital
number and date of birth
 Blood pressure, pulse and temperature
 Weight
 Blood glucose if diabetic
 Observe / assess patient for any other problems
or needs
 Observe access site – neckline / fistula / graft
Assess A-B-C
 Ambulation,access,
 Breathing
 Cardiovascular status
 Changes
Post Haemodialysis:
 After termination of dialysis, record Blood
pressure,pulse and temperature
 Blood glucose if diabetic
 Weight – assist to scales if necessary
 Observe access site to ensure no further
bleeding / dressing secure
Peritoneal Dialysis
 peritoneal
membrane =
partially permeable
membrane
 dextrose dialysate
 diffusion and
osmosis until
equilibrium
 3-10 dwells per
night with 2-2.5 L
per dwell
Indications for Dialysis
 Acidosis
 Electrolytes
 Ingestions
 Overload
 Uremia
Access
 Arteriovenous fistula (AVF)
 Graft
 Tunneled catheter
Arteriovenous Fistula
◦ Highest patency
◦ Lowest risk of infection
◦ Low risk of thrombus
◦ Maturation time (3-4mo)
◦ Steal syndrome (poor
blood supply to the rest
of the limb)
◦ Aneurysm formation
Arteriovenous Graft
 Easier to create
 Maturation time 3-6
weeks
 Poor patency (often
requires thrombectomy
or angioplasty)
 Infection
 Aneurysms
 Steal syndrome
Tunneled Catheter
 Immediate use
 Bridge to AVF/AVG
 Poor flow (decreased
HD efficiency)
 High infection risk
 Venous stenosis
 Thrombosis
Dialysis Rx:
 Time: 2-5 hours
 Bath
 Blood flow rate: 400-450cc/min
 Dialysate flow rate: 500-800cc/min
 Anticoagulant
 Additives:
◦ Anemia (EPO, blood)
◦ Bone metabolism (vit D, calcitriol, etc)
◦ Meds (antibiotics)
Dialysate Bath
Common Admissions on Eckel
 Complications of missed HD
◦ SOB from fluid overload
◦ HTN crisis
◦ Hyperkalemia
 Line infections
 Access issues
 And everything else…
Eckel Pearls: presentation
75 yo AAM with ESRD 2/2 DM (HD MWF
via RUE AVF, at CDC East, nephrologist
Dr.Wish, dry weight 82kg, oligouric)
Eckel Pearls: history
 how did the last HD session go?
 complications since being started on HD?
◦ infections?
◦ multiple access points?
 medically compliant?
 get run sheets from dialysis center
Eckel Pearls: physical exam
 Vitals: no BP in the arm of the access
 Volume status
 Access:
◦ Infection?
◦ Aneurysms
◦ Bruits/thrills
Dialysis
Page 1
 RN LK50: OMG’s K is 3.1. Can we
replete?
•Had dialysis 3rd shift. Finished 2hrs ago
Labs in ESRD
 Get labs before or 4h after HD
 Only the H/H is accurate
 Floor RNs can’t use HD lines
 Can ask to have cultures drawn at HD
from the line
Page 2
 RN LK20: New admit AMS on floor. Hard to
arouse. Please eval
 ED presentation with abd pain
 Workup initiated since there are no beds…
 Pain meds: morphine 1mg, then 1mg, then 2
mg, then 3mg IVP
 Sent to the floor
Medications in ESRD
 Antibiotics
◦ Renally dose
◦ Loading dose, then maintenance dose
 No lovenox dvt ppx, use heparin
 No morphine
◦ Hepatic metabolism – but active metabolites
◦ Limit the other opioids
 Dilaudid: hepatic metabolism – but metabolites can
cause neuroexcitiation
 constipation/GERD : avoid
magnesium/phosphate containing agents
Page 3
 RN: new admit OK. Called wound care for
leg.
 After lunch you walk on over to the patient
room. ESRD admitted for access.
 OK is doing ok. Vitals stable. Comfortable.
Dialysis
Calciphylaxis
Calcinosis cutis
Page 4
 RN LK20: Code white,WAA is hypoxic, 83% on
RA. Now 92% onVM.
 Acutely SOB. Looks uncomfortable.
 Your co-NF points that one leg is bigger than the
other.
 You ask,“have you had a blood clot before?”
 WAA nods yes.
 Hmmm….amongst other things, CTPE?
Imaging in CKD
 Avoid contrast in CKD patients
 If you have to, prep
◦ volume expansion: isotonic IVFs
 3 cc/kg x 1h before
 1cc/kg x 6h after
◦ ? alkalinization: sodium bicarbonate
◦ ? acetylcysteine
◦ radiology can give you the protocol
 (treat empirically)
Imaging in ESRD
 CT with contrast is ok
 MRI with gadolinium is NOT:
◦ Nephrogenic Systemic Fibrosis (NSF)
◦ IF you must: HD x 3 over 3 consecutive days,
with the first right after
Page 5
 RN LK20: Lost access on GRR. Can you
order a PICC?
 Finally, an easy question.
 CKD. Sure, why not?
Access in CKD
 Avoid PICC/midlines in CKD stage 4-5
 Try to preserve access
 Try for the feet/EJ
 But if you need to, order a midline
 PCP should refer CKD stage IV to
nephrologists in anticipation of HD
Don’t treat them lightly
The end.
Dialysis Patients at Risk
for Infection
Why are Dialysis Patients at Risk for
Infection?
◦ Frequent use of catheters or insertion of needles
to access the bloodstream
◦ Weakened immune systems
◦ Frequent hospital stays and surgery
 Dialysis patients are at risk of getting hepatitis B
and C infections and bloodstream infections
◦ Hepatitis B and C are bloodborne
viral infections that can cause chronic
(life-long) disease involving
inflammation (swelling) of the liver
 Hepatitis B and C viruses can live on
surfaces and be spread without visible blood
◦ A bloodstream infection is a serious infection that can
occur when bacteria or other germs get into the blood
 One way bacteria can enter the bloodstream is through a vascular
access (catheter, fistula, or graft)
Infections in Dialysis Patients
• Advise patients to inform you if they notice any of the following
possible signs of infection:
– Fever
– The access site is:
• Swollen (bulging),
• red,
• warm, or
• has pus
– Severe pain at the access site
Remember: infections of the vascular
access site can be life threatening
How to Recognize an Infection
 Bloodstream infections are a dangerous complication of
dialysis
 1 in 4 patients who get a
bloodstream infection caused by
S. aureus (staph) bacteria can face
complications such as:
◦ Endocarditis (infected heart valve)
◦ Osteomyelitis (infected bone)
 Total costs for each infection can be more than $20,000
 Bloodstream infections can cause sepsis (a potentially deadly
condition)
 Up to 1 in 5 patients with an infection die within 12 weeks
Infections in Dialysis Patients
Basic Steps in Fistula/Graft Care
Cannulation Procedure:
1. Wash the site
2. Perform hand hygiene
3. Put on a new, clean pair of gloves
4. Wear proper face protection
5. Apply skin antiseptic and allow it
to dry
6. Insert needle using aseptic
technique
7. Remove gloves and perform hand
hygiene
Aseptic technique means taking great care to not contaminate the fistula
or graft site before or during the cannulation or decannulation procedure
Photo provided by Stephanie Booth, used with permission
Basic Steps in Catheter Care
Catheter Connection Procedure:
1. Perform hand hygiene
2. Put on a new, clean pair of gloves
3. Wear proper face protection
4. Apply antiseptic to catheter hub and allow it to dry
5. Connect the catheter to blood lines using aseptic technique
6. Unclamp the catheter
7. Remove gloves and perform hand hygiene
Basic Steps in Catheter Care
Catheter Disconnection Procedure:
1. Perform hand hygiene
2. Put on a new, clean pair of gloves
3. Wear proper face protection
4. Disconnect the catheter from blood lines using aseptic
technique
5. Apply antiseptic to catheter hub and allow it to dry
6. Replace caps using aseptic technique
7. Make sure the catheter remains clamped
8. Remove gloves and perform hand hygiene
Catheter Exit Site Care
1. Perform hand hygiene
2. Put on a new, clean pair of gloves
3. Wear a face mask if required
4. Apply antiseptic to catheter exit
site and allow it to dry
5. Apply antimicrobial ointment
6. Apply clean dressing to exit site
7. Remove gloves and perform hand
hygiene
Photo provided by Stephanie Booth, used with permission
Separate Clean Areas from Contaminated
Areas
• Clean areas should be used for the
preparation, handling and storage of
medications and unused supplies and equipment
– Your center should have clean medication and
clean supply areas
• Contaminated areas are where used
supplies and equipment are handled
• Do not handle or store medications or clean
supplies in the same area as where used
equipment or blood samples are handled
Remember:Treatment stations are contaminated areas!
Clean area
Photo provided by Stephanie Booth, used with permission
Dedicate Supplies to a Single Patient
• Any item taken to a patient’s dialysis
station could become contaminated
• Items taken into the dialysis station
should either be:
– Disposed of, or
– Cleaned and disinfected before being taken
to a common clean area or used on
another patient
• Unused medications or supplies taken
to the patient’s station should not be
returned to a common clean area (e.g.,
medication vials, syringes, alcohol
swabs)
Photo provided by Marshia Coe and Teresa Hoosier, used with permission
Safe Use of MedicationVials
• Prepare all individual patient doses in a
clean area away from dialysis stations
• Prepare doses as close as possible to the
time of use
• Do not carry medications from station
to station
• Do not prepare or store medications at
patient stations
• CDC recommends that dialysis facilities:
– Use single-dose vials whenever possible and
dispose of them immediately after use
Guidelines for Carrying Medications
 Do not use the same medication cart to deliver
medications to multiple patients
 Do not carry medication vials, syringes, alcohol swabs, or
supplies in pockets
 Be sure to prepare the medication in a clean area away
from the patient station and bring it to the patient station
for that patient only at the time of use
 Cleaning and disinfection reduce the risk of spreading an
infection
 Cleaning is done using cleaning detergent,
water and friction, and is intended to
remove blood, body fluids, and other
contaminants from objects and surfaces
 Disinfection is a process that kills many
or all remaining infection-causing
germs on clean objects and surfaces
◦ Use an EPA-registered hospital disinfectant
◦ Follow label instructions for proper dilution
 Wear gloves during the cleaning/disinfection process
Cleaning and Disinfecting the
Dialysis Station
 All equipment and surfaces are considered to be
contaminated after a dialysis session and therefore must be
disinfected
 After the patient leaves the station,
disinfect the dialysis station
(including chairs, trays, countertops,
and machines) after each patient
treatment
◦ Wipe all surfaces
◦ Surfaces should be wet with disinfectant and allowed to air dry
◦ Give special attention to cleaning control panels on the dialysis
machines and other commonly touched surfaces
◦ Empty and disinfect all surfaces of prime waste containers
Disinfecting the Dialysis Station
Photo provided by Stephanie Booth, used with permission
Safe Handling of Dialyzers and
Blood Tubing
• Before removing or transporting used
dialyzers and blood tubing, cap dialyzer
ports and clamp tubing
• Place all used dialyzers and tubing in
leak-proof containers for transport
from station to reprocessing or
disposal area
• If dialyzers are reused, follow
published methods (e.g.,AAMI
standards) for reprocessing
AAMI is the Association for the Advancement of Medical
Instrumentation
Photo provided by Stephanie Booth, used with permission
Conclusion
 Infections that patients can get while receiving dialysis are
serious and preventable!
 Healthcare workers like you following infection control
precautions and other safe care practices are the key to
prevention
 Infection prevention is everyone’s responsibility

Contenu connexe

Tendances (20)

14 peritoneal dialysis
14 peritoneal dialysis14 peritoneal dialysis
14 peritoneal dialysis
 
Dialysis
DialysisDialysis
Dialysis
 
Arteriovenous graft
Arteriovenous graftArteriovenous graft
Arteriovenous graft
 
Continuous renal replacement therapy
Continuous renal replacement therapyContinuous renal replacement therapy
Continuous renal replacement therapy
 
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
SUSTAINED LOW EFFICIENCY DAILY DIALYSIS (SLEDD)
 
Acute peritoneal dialysis prescription
Acute peritoneal dialysis prescriptionAcute peritoneal dialysis prescription
Acute peritoneal dialysis prescription
 
Hemodialysis
HemodialysisHemodialysis
Hemodialysis
 
CONTINUOUS RENAL REPLACEMENT THERAPY Crrt 2
CONTINUOUS RENAL REPLACEMENT THERAPY Crrt  2CONTINUOUS RENAL REPLACEMENT THERAPY Crrt  2
CONTINUOUS RENAL REPLACEMENT THERAPY Crrt 2
 
Temporary vascular access for hemodialysis
Temporary vascular access for hemodialysisTemporary vascular access for hemodialysis
Temporary vascular access for hemodialysis
 
CAPD
CAPDCAPD
CAPD
 
Dialysis seminar by Kiran Bhardwaj
Dialysis seminar by Kiran BhardwajDialysis seminar by Kiran Bhardwaj
Dialysis seminar by Kiran Bhardwaj
 
DIALYSIS WATER TREATMENT
DIALYSIS WATER TREATMENTDIALYSIS WATER TREATMENT
DIALYSIS WATER TREATMENT
 
Permnent vascular access
Permnent vascular accessPermnent vascular access
Permnent vascular access
 
Dialysis basics
Dialysis basicsDialysis basics
Dialysis basics
 
Vascular access
Vascular accessVascular access
Vascular access
 
Cardiac arrest in the dialysis unit
Cardiac arrest in the dialysis unitCardiac arrest in the dialysis unit
Cardiac arrest in the dialysis unit
 
Dialysis machines key features
Dialysis machines key featuresDialysis machines key features
Dialysis machines key features
 
Adequacy of haemodialysis
Adequacy of haemodialysisAdequacy of haemodialysis
Adequacy of haemodialysis
 
Principles of hemodialysis final 2017
Principles of hemodialysis final  2017Principles of hemodialysis final  2017
Principles of hemodialysis final 2017
 
HD machine
HD machineHD machine
HD machine
 

En vedette (13)

Dialysis
DialysisDialysis
Dialysis
 
Kidney dialysis
Kidney dialysisKidney dialysis
Kidney dialysis
 
Dialysis machine (2)
Dialysis machine (2)Dialysis machine (2)
Dialysis machine (2)
 
Dialysis
Dialysis Dialysis
Dialysis
 
HEMODIALYSIS MACHINE
HEMODIALYSIS MACHINEHEMODIALYSIS MACHINE
HEMODIALYSIS MACHINE
 
Hemodialysis Unit
Hemodialysis UnitHemodialysis Unit
Hemodialysis Unit
 
Hemodialysis and peritoneal dialysis
Hemodialysis and peritoneal dialysisHemodialysis and peritoneal dialysis
Hemodialysis and peritoneal dialysis
 
Hemodialysis,
Hemodialysis,Hemodialysis,
Hemodialysis,
 
Hemodialysis
HemodialysisHemodialysis
Hemodialysis
 
Nursing Care of Patient on Dialysis
Nursing Care  of Patient on DialysisNursing Care  of Patient on Dialysis
Nursing Care of Patient on Dialysis
 
Dialysis
DialysisDialysis
Dialysis
 
Dialysis
DialysisDialysis
Dialysis
 
Hemodialysis Final
Hemodialysis FinalHemodialysis Final
Hemodialysis Final
 

Similaire à Dialysis

SIADH
SIADHSIADH
SIADHaungp
 
Acute kidney injury by dr babalola
Acute kidney injury by dr babalolaAcute kidney injury by dr babalola
Acute kidney injury by dr babalolaToluwaniBabalola1
 
Approach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptxApproach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptxMariaFatima374066
 
CHRONIC KIDENY DISEASE ......CKD ........DR ASEM MOH.ABOU ISSA.....NEPHROL...
CHRONIC KIDENY DISEASE  ......CKD ........DR   ASEM MOH.ABOU ISSA.....NEPHROL...CHRONIC KIDENY DISEASE  ......CKD ........DR   ASEM MOH.ABOU ISSA.....NEPHROL...
CHRONIC KIDENY DISEASE ......CKD ........DR ASEM MOH.ABOU ISSA.....NEPHROL...Asem Mohamed
 
Fluid and electrolyte balance11
Fluid and electrolyte balance11Fluid and electrolyte balance11
Fluid and electrolyte balance11Lama K Banna
 
Approach to patient with hypo/hyper calcaemia
Approach to patient with hypo/hyper calcaemiaApproach to patient with hypo/hyper calcaemia
Approach to patient with hypo/hyper calcaemiaNassr ALBarhi
 
Complications of chronic liver disease
Complications of chronic liver diseaseComplications of chronic liver disease
Complications of chronic liver diseaseSayed Zaki
 
Nephrogenic diabetes insipidus
Nephrogenic diabetes insipidusNephrogenic diabetes insipidus
Nephrogenic diabetes insipidusrajendrashilpakar
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxYuyunRasulong1
 
Renal failure in children
Renal failure in children Renal failure in children
Renal failure in children Nahar Kamrun
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dmsiifan23
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury AIIMS, New Delhi, India
 

Similaire à Dialysis (20)

SIADH
SIADHSIADH
SIADH
 
Acute kidney injury by dr babalola
Acute kidney injury by dr babalolaAcute kidney injury by dr babalola
Acute kidney injury by dr babalola
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Nephrotic.pptx
Nephrotic.pptxNephrotic.pptx
Nephrotic.pptx
 
Approach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptxApproach to a patient with Hyponatremia.pptx
Approach to a patient with Hyponatremia.pptx
 
CHRONIC KIDENY DISEASE ......CKD ........DR ASEM MOH.ABOU ISSA.....NEPHROL...
CHRONIC KIDENY DISEASE  ......CKD ........DR   ASEM MOH.ABOU ISSA.....NEPHROL...CHRONIC KIDENY DISEASE  ......CKD ........DR   ASEM MOH.ABOU ISSA.....NEPHROL...
CHRONIC KIDENY DISEASE ......CKD ........DR ASEM MOH.ABOU ISSA.....NEPHROL...
 
RPGN.pptx
RPGN.pptxRPGN.pptx
RPGN.pptx
 
Fluid and electrolyte balance11
Fluid and electrolyte balance11Fluid and electrolyte balance11
Fluid and electrolyte balance11
 
Acute renal failure
Acute renal failureAcute renal failure
Acute renal failure
 
Approach to patient with hypo/hyper calcaemia
Approach to patient with hypo/hyper calcaemiaApproach to patient with hypo/hyper calcaemia
Approach to patient with hypo/hyper calcaemia
 
AKI and CKD.ppt
AKI and CKD.pptAKI and CKD.ppt
AKI and CKD.ppt
 
Complications of chronic liver disease
Complications of chronic liver diseaseComplications of chronic liver disease
Complications of chronic liver disease
 
Nephrogenic diabetes insipidus
Nephrogenic diabetes insipidusNephrogenic diabetes insipidus
Nephrogenic diabetes insipidus
 
Laporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptxLaporan Jaga CRBSI.pptx
Laporan Jaga CRBSI.pptx
 
Group 3 Fisher
Group 3 FisherGroup 3 Fisher
Group 3 Fisher
 
Renal failure in children
Renal failure in children Renal failure in children
Renal failure in children
 
Pd intervention-1
Pd   intervention-1Pd   intervention-1
Pd intervention-1
 
Fluid & Electrolytes - Copy.ppt
Fluid & Electrolytes - Copy.pptFluid & Electrolytes - Copy.ppt
Fluid & Electrolytes - Copy.ppt
 
Approch to a patient with acut comlications of dm
Approch to a patient  with acut comlications of dmApproch to a patient  with acut comlications of dm
Approch to a patient with acut comlications of dm
 
Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury Approach to a Patient with Acute kidney injury
Approach to a Patient with Acute kidney injury
 

Plus de BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL

Plus de BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL (20)

Jiwani of RS Mehta book.pdf
Jiwani of RS Mehta book.pdfJiwani of RS Mehta book.pdf
Jiwani of RS Mehta book.pdf
 
Ph.D. Thesis on HBC by RS Mehta.pdf
Ph.D. Thesis on HBC by RS Mehta.pdfPh.D. Thesis on HBC by RS Mehta.pdf
Ph.D. Thesis on HBC by RS Mehta.pdf
 
M. Sc. Nursing Thesis by RS Mehta.pdf
M. Sc. Nursing Thesis  by RS Mehta.pdfM. Sc. Nursing Thesis  by RS Mehta.pdf
M. Sc. Nursing Thesis by RS Mehta.pdf
 
Ph.D. Thesis on HBC by RS Mehta.pdf
Ph.D. Thesis on HBC by RS Mehta.pdfPh.D. Thesis on HBC by RS Mehta.pdf
Ph.D. Thesis on HBC by RS Mehta.pdf
 
bsc pancreatitis 8.pptx
bsc pancreatitis 8.pptxbsc pancreatitis 8.pptx
bsc pancreatitis 8.pptx
 
12-lead EKG Interpretation1.pdf
12-lead EKG Interpretation1.pdf12-lead EKG Interpretation1.pdf
12-lead EKG Interpretation1.pdf
 
4. Advocacy in Nursing.pdf
4. Advocacy in Nursing.pdf4. Advocacy in Nursing.pdf
4. Advocacy in Nursing.pdf
 
3. Legal Aspects in Nursing.pdf
3. Legal Aspects in Nursing.pdf3. Legal Aspects in Nursing.pdf
3. Legal Aspects in Nursing.pdf
 
1. Ethics and Values.pdf
1. Ethics and Values.pdf1. Ethics and Values.pdf
1. Ethics and Values.pdf
 
2. ICN Code for Nursing Ethics.pdf
2. ICN Code for Nursing Ethics.pdf2. ICN Code for Nursing Ethics.pdf
2. ICN Code for Nursing Ethics.pdf
 
RS MEHTA Photos 24 yrs in BPKIHS.ppsx
RS MEHTA Photos 24 yrs in BPKIHS.ppsxRS MEHTA Photos 24 yrs in BPKIHS.ppsx
RS MEHTA Photos 24 yrs in BPKIHS.ppsx
 
9. Experiences of Singapore CGH.ppsx
9. Experiences of Singapore CGH.ppsx9. Experiences of Singapore CGH.ppsx
9. Experiences of Singapore CGH.ppsx
 
International Visit by RS MEHTA.ppsx
International  Visit by RS MEHTA.ppsxInternational  Visit by RS MEHTA.ppsx
International Visit by RS MEHTA.ppsx
 
Ram Sharan Mehta Jiwani
Ram Sharan Mehta Jiwani Ram Sharan Mehta Jiwani
Ram Sharan Mehta Jiwani
 
4. advocacy in nursing
4. advocacy in nursing4. advocacy in nursing
4. advocacy in nursing
 
3. legal aspects in nursing
3. legal aspects in nursing3. legal aspects in nursing
3. legal aspects in nursing
 
2. icn code for nursing ethics
2. icn code for nursing ethics2. icn code for nursing ethics
2. icn code for nursing ethics
 
1. ethics and values
1. ethics and values1. ethics and values
1. ethics and values
 
CV Ram Sharan Mehta
CV Ram Sharan MehtaCV Ram Sharan Mehta
CV Ram Sharan Mehta
 
Rs mehta photos of visits historical
Rs mehta photos of visits historicalRs mehta photos of visits historical
Rs mehta photos of visits historical
 

Dernier

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptxNIKITA BHUTE
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 

Dernier (20)

Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptxORAL HYPOGLYCAEMIC AGENTS  - PART 2.pptx
ORAL HYPOGLYCAEMIC AGENTS - PART 2.pptx
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 

Dialysis

  • 1. Renal Disease and Dialysis
  • 5. Common Diagnosis  CKD (ESRD) secondary to hypertensive nephropathy  Acute gastroenteritis  AKI,Acute gastroenteritis  CKD (ESRD) secondary to chronic glomerulonephritis  CKD(ESRD) secondary to Diabetic nephropathy
  • 6. Indications End-stage renal failure – GFR less than 5 ml/min( dialysis or renal transplant is needed).
  • 7. Contd…  Clinical  Fluid overload not responding to diuretics.  Uremic convulsion  Persistent dyspnea, vomiting and restlessness.  Signs of pericarditis, pericardial effusion, pericardial friction rub.  Biochemical Chemical ARF CRF Normal Urea >35 mmol/L >40 mmol/L 2.5-6.5 Creatinine >12-14 mg/dl >12-14 mg/dl 0.6-1.3 Potassium >6.5 Meq/L >6.5 Meq/L 3.5-5.5 PH <7.1 <7. 1 7.35- 7.45
  • 8. Hours for hemodialysis  Hemodialysis usually is done three times a week.  Each treatment lasts from 2 to 4 hours. During treatment, patient can read, write, sleep, talk, or watchTV.
  • 10. Hemodialysis  Semipermeable membrane  Solute removal via passive diffusion ◦ Inversely proportional to the size (ie effective removal of K, urea, C; not of PO4)
  • 12. Ultrafiltration  use of hydrostatic pressure gradient to induce convection (filtration of water)  solvent drag (pulls dissolved solutes) across  removal of excess fluid
  • 13. CVVH  highly permeable membrane  fluid and solute removal via ultrafiltration  filtrate is discarded  replacement fluid is infused similar to plasma (but no K, urea, Cr, PO4)  used in ICU, runs 12-24h, through double lumen catheter  less drastic fluid shifts
  • 14. Preparations for Dialysis  Articles needed for dialysis i. Arteriovenous fistula : common venous access for HD. Usually radial artery and cephalic vein are anastomosed.  Dialyser set  Arteriovenous set  Fistula needle  Haemodialysis fluid with bicarbonate powder (5 litre)  IV set
  • 15. …  Inj. 25% Dextrose : If associated with Diabetes, Diabetic Uropathy , Diabetic Nephropathy.  Inj. Normal Saline(500 ml)  Inj Avil  Inj Heparin  Syringes : 20, 10 & 5 cc.
  • 16. … ii.Via Femoral (It is done through through femoral vein  Dialyser set  Arteriovenous set  Femoral Catheter  GuideWire Straight tip (70cm)  Haemodialysis fluid with Bicarbonate powder ( 5litre)  IV canula
  • 17. …  IV set  Inj. 25 % Dextrose  Inj 2% Xylocaine  Inj. Normal Saline 500ml  Inj.Avil  Inj. Heparin  Syringes : 20, 10 , 5 cc.
  • 18. Chemicals Used In Dialysis Sodium Hypochlorite Hydrogen Peroxide Formaldehyde
  • 19. Part A and part B i. Part A Concentrate contains :  Sodium Chloride : 173.65 gm/l  Potassium Chloride : 5.06 gm/l  Calcium Chloride : 8.75 gm/l  Magnesium Chloride : 5.18 gm/l  Glacial Acetic Acid : 8.17gm/l
  • 20. … ii. Part B  Sodium Bicarbonate : 626gm  Sodium Chloride : 221 gm (mixed with 9 litres of Reverse Osmosis water)
  • 21. Medication used during dialysis  Heparin :6000 IU Side Effects of Heparin : Pruritus, Allergy ,Osteoporosis, Hyperlipidemia, Thrombocytopenia  Avil : 1 Ampoule (each ml contains 22.75 mg)  Hydrocortisone :1vial = 100 mg  25% dextrose:  Epofit
  • 22. Heparin free case  Periodic saline rinse  Every 15-30 minutes , rinse the dialyser rapidly with 100-250 ml of saline while occluding the blood inlet line.  The purpose of the periodic rinsing is to allow inspection of a hollow-fiber dialyser for evidence of clotting.
  • 23. Hypoglycemia: It can develop in diabetic patient treated with either hemodialysis or peritoneal dialysis and is usually due to reduced insulin catabolism and to reduce intake and absorption of food.
  • 24.  In diabetic patients hemodialysis solution should always contain about 200mg/dl glucose if not added then severe hypoglycemia during or soon after hemodialysis can result.
  • 25. Investigation  Haemoglobin :15 days  Urea, creatinine,Na+, K+ : 1 month  Serology : 2 months
  • 26.  Range of conductivity:14.7mMho13.2mMho  Normal range of TMP: -100 to 500  The usual flow rate for adult patient is 200-350 ml/min
  • 28. Financial  Amount of 5 lakhs is provided by the government for dialysis
  • 29. Complications  Infection  Fever and chills  Catheter clotting  Hypotension  Muscle cramps  Septicemia  Hepatits C
  • 30. Prognosis(Life expectancy)  2-4 years in haemodialysis  9-10 years in CAPD
  • 31.  Disequilibrium Syndrome : It is the set of systemic and neurologic symptoms often associated with characteristic EEG findings that can occur either during or soon after dialysis . Early manifestation:nausea ,vomiting ,restlesssness ,headache Serious manifestation : coma, seizure
  • 32. Care of vascular access  Check access before each treatment.  Keep access clean at all times. Do not use cream or lotion over the site.  Use access site only for dialysis.  Be careful not to bump or cut access.  Don’t put a blood pressure cuff on access arm.  Remove jewellary or tight clothes over access site.  Don’t sleep with access arm under your head or body.  Don’t lift heavy objects or put pressure on access arm.
  • 33. Diet Pattern  Fluid restriction: total intake<1 lit/day in oliguric ARF and total intake <urine output + extra renal loss  Total caloric intake– 35~ 50 kcal/kg/day to avoid catabolism  Salt restriction– 2~4 g/day  Potassium intake– 40 meq/day  Phosphorus intake– 800 mg/day
  • 34.  Daily protein intake of between 0.60 and 0.75gm/kg/day.  The normal level of potassium intake is 3.5-5.0 mEq/l.  2-3g/day of sodium is allowed in CKD patient.  Phosphorus consumption for normal people as well as people with CKD for non dialysis is 2.7-4.6mg/dl.  For CKD dialysis patients the target range is 3.5- 5.5mg/dl.
  • 35. Dialyzer Re-use 1. Reprocessing technique : The major steps in dialyzer reuse are rinsing , cleaning, measurement of dialyzer performance, disinfection/sterilization and germicide removal. a) Rinsing and reverse ultrafiltration b) Cleaning : Sodium hypochlorite c) Other cleaning agents : Hydrogen peroxide,formalin
  • 36. Nursing consideration Pre Haemodialysis:  Correct identification of patient, using hospital number and date of birth  Blood pressure, pulse and temperature  Weight  Blood glucose if diabetic  Observe / assess patient for any other problems or needs  Observe access site – neckline / fistula / graft
  • 37. Assess A-B-C  Ambulation,access,  Breathing  Cardiovascular status  Changes
  • 38. Post Haemodialysis:  After termination of dialysis, record Blood pressure,pulse and temperature  Blood glucose if diabetic  Weight – assist to scales if necessary  Observe access site to ensure no further bleeding / dressing secure
  • 39. Peritoneal Dialysis  peritoneal membrane = partially permeable membrane  dextrose dialysate  diffusion and osmosis until equilibrium  3-10 dwells per night with 2-2.5 L per dwell
  • 40. Indications for Dialysis  Acidosis  Electrolytes  Ingestions  Overload  Uremia
  • 41. Access  Arteriovenous fistula (AVF)  Graft  Tunneled catheter
  • 42. Arteriovenous Fistula ◦ Highest patency ◦ Lowest risk of infection ◦ Low risk of thrombus ◦ Maturation time (3-4mo) ◦ Steal syndrome (poor blood supply to the rest of the limb) ◦ Aneurysm formation
  • 43. Arteriovenous Graft  Easier to create  Maturation time 3-6 weeks  Poor patency (often requires thrombectomy or angioplasty)  Infection  Aneurysms  Steal syndrome
  • 44. Tunneled Catheter  Immediate use  Bridge to AVF/AVG  Poor flow (decreased HD efficiency)  High infection risk  Venous stenosis  Thrombosis
  • 45. Dialysis Rx:  Time: 2-5 hours  Bath  Blood flow rate: 400-450cc/min  Dialysate flow rate: 500-800cc/min  Anticoagulant  Additives: ◦ Anemia (EPO, blood) ◦ Bone metabolism (vit D, calcitriol, etc) ◦ Meds (antibiotics)
  • 47. Common Admissions on Eckel  Complications of missed HD ◦ SOB from fluid overload ◦ HTN crisis ◦ Hyperkalemia  Line infections  Access issues  And everything else…
  • 48. Eckel Pearls: presentation 75 yo AAM with ESRD 2/2 DM (HD MWF via RUE AVF, at CDC East, nephrologist Dr.Wish, dry weight 82kg, oligouric)
  • 49. Eckel Pearls: history  how did the last HD session go?  complications since being started on HD? ◦ infections? ◦ multiple access points?  medically compliant?  get run sheets from dialysis center
  • 50. Eckel Pearls: physical exam  Vitals: no BP in the arm of the access  Volume status  Access: ◦ Infection? ◦ Aneurysms ◦ Bruits/thrills
  • 52. Page 1  RN LK50: OMG’s K is 3.1. Can we replete? •Had dialysis 3rd shift. Finished 2hrs ago
  • 53. Labs in ESRD  Get labs before or 4h after HD  Only the H/H is accurate  Floor RNs can’t use HD lines  Can ask to have cultures drawn at HD from the line
  • 54. Page 2  RN LK20: New admit AMS on floor. Hard to arouse. Please eval  ED presentation with abd pain  Workup initiated since there are no beds…  Pain meds: morphine 1mg, then 1mg, then 2 mg, then 3mg IVP  Sent to the floor
  • 55. Medications in ESRD  Antibiotics ◦ Renally dose ◦ Loading dose, then maintenance dose  No lovenox dvt ppx, use heparin  No morphine ◦ Hepatic metabolism – but active metabolites ◦ Limit the other opioids  Dilaudid: hepatic metabolism – but metabolites can cause neuroexcitiation  constipation/GERD : avoid magnesium/phosphate containing agents
  • 56. Page 3  RN: new admit OK. Called wound care for leg.  After lunch you walk on over to the patient room. ESRD admitted for access.  OK is doing ok. Vitals stable. Comfortable.
  • 59. Page 4  RN LK20: Code white,WAA is hypoxic, 83% on RA. Now 92% onVM.  Acutely SOB. Looks uncomfortable.  Your co-NF points that one leg is bigger than the other.  You ask,“have you had a blood clot before?”  WAA nods yes.  Hmmm….amongst other things, CTPE?
  • 60. Imaging in CKD  Avoid contrast in CKD patients  If you have to, prep ◦ volume expansion: isotonic IVFs  3 cc/kg x 1h before  1cc/kg x 6h after ◦ ? alkalinization: sodium bicarbonate ◦ ? acetylcysteine ◦ radiology can give you the protocol  (treat empirically)
  • 61. Imaging in ESRD  CT with contrast is ok  MRI with gadolinium is NOT: ◦ Nephrogenic Systemic Fibrosis (NSF) ◦ IF you must: HD x 3 over 3 consecutive days, with the first right after
  • 62. Page 5  RN LK20: Lost access on GRR. Can you order a PICC?  Finally, an easy question.  CKD. Sure, why not?
  • 63. Access in CKD  Avoid PICC/midlines in CKD stage 4-5  Try to preserve access  Try for the feet/EJ  But if you need to, order a midline  PCP should refer CKD stage IV to nephrologists in anticipation of HD
  • 66. Dialysis Patients at Risk for Infection
  • 67. Why are Dialysis Patients at Risk for Infection? ◦ Frequent use of catheters or insertion of needles to access the bloodstream ◦ Weakened immune systems ◦ Frequent hospital stays and surgery
  • 68.  Dialysis patients are at risk of getting hepatitis B and C infections and bloodstream infections ◦ Hepatitis B and C are bloodborne viral infections that can cause chronic (life-long) disease involving inflammation (swelling) of the liver  Hepatitis B and C viruses can live on surfaces and be spread without visible blood ◦ A bloodstream infection is a serious infection that can occur when bacteria or other germs get into the blood  One way bacteria can enter the bloodstream is through a vascular access (catheter, fistula, or graft) Infections in Dialysis Patients
  • 69. • Advise patients to inform you if they notice any of the following possible signs of infection: – Fever – The access site is: • Swollen (bulging), • red, • warm, or • has pus – Severe pain at the access site Remember: infections of the vascular access site can be life threatening How to Recognize an Infection
  • 70.  Bloodstream infections are a dangerous complication of dialysis  1 in 4 patients who get a bloodstream infection caused by S. aureus (staph) bacteria can face complications such as: ◦ Endocarditis (infected heart valve) ◦ Osteomyelitis (infected bone)  Total costs for each infection can be more than $20,000  Bloodstream infections can cause sepsis (a potentially deadly condition)  Up to 1 in 5 patients with an infection die within 12 weeks Infections in Dialysis Patients
  • 71. Basic Steps in Fistula/Graft Care Cannulation Procedure: 1. Wash the site 2. Perform hand hygiene 3. Put on a new, clean pair of gloves 4. Wear proper face protection 5. Apply skin antiseptic and allow it to dry 6. Insert needle using aseptic technique 7. Remove gloves and perform hand hygiene Aseptic technique means taking great care to not contaminate the fistula or graft site before or during the cannulation or decannulation procedure Photo provided by Stephanie Booth, used with permission
  • 72. Basic Steps in Catheter Care Catheter Connection Procedure: 1. Perform hand hygiene 2. Put on a new, clean pair of gloves 3. Wear proper face protection 4. Apply antiseptic to catheter hub and allow it to dry 5. Connect the catheter to blood lines using aseptic technique 6. Unclamp the catheter 7. Remove gloves and perform hand hygiene
  • 73. Basic Steps in Catheter Care Catheter Disconnection Procedure: 1. Perform hand hygiene 2. Put on a new, clean pair of gloves 3. Wear proper face protection 4. Disconnect the catheter from blood lines using aseptic technique 5. Apply antiseptic to catheter hub and allow it to dry 6. Replace caps using aseptic technique 7. Make sure the catheter remains clamped 8. Remove gloves and perform hand hygiene
  • 74. Catheter Exit Site Care 1. Perform hand hygiene 2. Put on a new, clean pair of gloves 3. Wear a face mask if required 4. Apply antiseptic to catheter exit site and allow it to dry 5. Apply antimicrobial ointment 6. Apply clean dressing to exit site 7. Remove gloves and perform hand hygiene Photo provided by Stephanie Booth, used with permission
  • 75. Separate Clean Areas from Contaminated Areas • Clean areas should be used for the preparation, handling and storage of medications and unused supplies and equipment – Your center should have clean medication and clean supply areas • Contaminated areas are where used supplies and equipment are handled • Do not handle or store medications or clean supplies in the same area as where used equipment or blood samples are handled Remember:Treatment stations are contaminated areas! Clean area Photo provided by Stephanie Booth, used with permission
  • 76. Dedicate Supplies to a Single Patient • Any item taken to a patient’s dialysis station could become contaminated • Items taken into the dialysis station should either be: – Disposed of, or – Cleaned and disinfected before being taken to a common clean area or used on another patient • Unused medications or supplies taken to the patient’s station should not be returned to a common clean area (e.g., medication vials, syringes, alcohol swabs) Photo provided by Marshia Coe and Teresa Hoosier, used with permission
  • 77. Safe Use of MedicationVials • Prepare all individual patient doses in a clean area away from dialysis stations • Prepare doses as close as possible to the time of use • Do not carry medications from station to station • Do not prepare or store medications at patient stations • CDC recommends that dialysis facilities: – Use single-dose vials whenever possible and dispose of them immediately after use
  • 78. Guidelines for Carrying Medications  Do not use the same medication cart to deliver medications to multiple patients  Do not carry medication vials, syringes, alcohol swabs, or supplies in pockets  Be sure to prepare the medication in a clean area away from the patient station and bring it to the patient station for that patient only at the time of use
  • 79.  Cleaning and disinfection reduce the risk of spreading an infection  Cleaning is done using cleaning detergent, water and friction, and is intended to remove blood, body fluids, and other contaminants from objects and surfaces  Disinfection is a process that kills many or all remaining infection-causing germs on clean objects and surfaces ◦ Use an EPA-registered hospital disinfectant ◦ Follow label instructions for proper dilution  Wear gloves during the cleaning/disinfection process Cleaning and Disinfecting the Dialysis Station
  • 80.  All equipment and surfaces are considered to be contaminated after a dialysis session and therefore must be disinfected  After the patient leaves the station, disinfect the dialysis station (including chairs, trays, countertops, and machines) after each patient treatment ◦ Wipe all surfaces ◦ Surfaces should be wet with disinfectant and allowed to air dry ◦ Give special attention to cleaning control panels on the dialysis machines and other commonly touched surfaces ◦ Empty and disinfect all surfaces of prime waste containers Disinfecting the Dialysis Station Photo provided by Stephanie Booth, used with permission
  • 81. Safe Handling of Dialyzers and Blood Tubing • Before removing or transporting used dialyzers and blood tubing, cap dialyzer ports and clamp tubing • Place all used dialyzers and tubing in leak-proof containers for transport from station to reprocessing or disposal area • If dialyzers are reused, follow published methods (e.g.,AAMI standards) for reprocessing AAMI is the Association for the Advancement of Medical Instrumentation Photo provided by Stephanie Booth, used with permission
  • 82. Conclusion  Infections that patients can get while receiving dialysis are serious and preventable!  Healthcare workers like you following infection control precautions and other safe care practices are the key to prevention  Infection prevention is everyone’s responsibility